Diamedica Therapeutics Inc (DMAC) returns
Diamedica Therapeutics returns over 10 years
$1,000 invested in Diamedica Therapeutics ten years ago was worth $2,345 at the close on October 30, 2026, with dividends reinvested: an average return of 8.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +11.9% | — | $1,119 | -0.9% |
| 3 months | +42.1% | — | $1,421 | +2.1% |
| Year to date | +16.2% | — | $1,162 | +11.7% |
| 1 year | +32.1% | — | $1,321 | +12.4% |
| 3 years | +330.2% | +62.6% | $4,302 | +88.5% |
| 5 years | +134.2% | +18.6% | $2,342 | +76.0% |
| 10 years | +134.5% | +8.9% | $2,345 | +316.6% |
Diamedica Therapeutics return by calendar year
| Year | DMAC | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +16.2% | +11.7% | +4.5% |
| 2025 | +46.6% | +17.7% | +28.9% |
| 2024 | +91.2% | +24.9% | +66.3% |
| 2023 | +79.7% | +26.2% | +53.5% |
| 2022 | -57.6% | -18.2% | -39.5% |
| 2021 | -63.2% | +28.7% | -92.0% |
| 2020 | +109.1% | +18.4% | +90.7% |
| 2019 | +66.7% | +31.2% | +35.4% |
| 2018 | -41.8% | -4.6% | -37.2% |
| 2017 | +127.7% | +21.7% | +106.0% |
| 2016 | +15.6% | +12.0% | +3.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Diamedica Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.